Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
gonadotropin-releasing hormone antagonist |
| gptkbp:approvedBy |
1999
|
| gptkbp:ATCCode |
gptkb:H01CC01
|
| gptkbp:brand |
gptkb:Orgalutran
|
| gptkbp:CASNumber |
gptkb:123246-29-7
|
| gptkbp:chemicalClass |
peptide
|
| gptkbp:developedBy |
gptkb:Organon
|
| gptkbp:eliminationHalfLife |
13-16 hours
|
| gptkbp:hasMolecularFormula |
C81H112ClN18O14
|
| https://www.w3.org/2000/01/rdf-schema#label |
Ganirelix
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
suppresses luteinizing hormone surge
|
| gptkbp:pregnancyCategory |
gptkb:category_X_(US)
|
| gptkbp:proteinBinding |
78.4%
|
| gptkbp:PubChem_CID |
CHEMBL1201207
25074465 |
| gptkbp:routeOfAdministration |
subcutaneous injection
|
| gptkbp:sideEffect |
nausea
abdominal pain headache injection site reactions |
| gptkbp:synonym |
gptkb:ganirelix_acetate
|
| gptkbp:UNII |
YFQ6T1F23F
|
| gptkbp:usedFor |
in vitro fertilization
assisted reproduction |
| gptkbp:bfsParent |
gptkb:MRK
|
| gptkbp:bfsLayer |
5
|